These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 32564470)

  • 1. A novel prognostic signature of immune-related genes for patients with colorectal cancer.
    Wang J; Yu S; Chen G; Kang M; Jin X; Huang Y; Lin L; Wu D; Wang L; Chen J
    J Cell Mol Med; 2020 Aug; 24(15):8491-8504. PubMed ID: 32564470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of an immune prognostic signature in colorectal cancer.
    Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
    Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
    Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
    Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an Immune Infiltration-Related Eight-Gene Prognostic Signature in Colorectal Cancer Microenvironment.
    Wu B; Tao L; Yang D; Li W; Xu H; He Q
    Biomed Res Int; 2020; 2020():2719739. PubMed ID: 32908876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and identification of immune-related genes for immunotherapy and prognostic assessment in colorectal cancer patients.
    Wang S; Cheng L; Jing F; Li G
    BMC Med Genomics; 2022 Aug; 15(1):177. PubMed ID: 35941638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A five-immune-related genes-based prognostic signature for colorectal cancer.
    Zhu L; Wang H; Wang Z
    Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a prognostic model based on an immunogenomic landscape analysis of colorectal cancer.
    Li HJ; Wang YL; Ming L; Guo XQ; Li YL; Wang JC; Zhang YQ; Cheng L
    Future Oncol; 2021 Jan; 17(3):301-313. PubMed ID: 32996773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of colorectal cancer.
    Li W; Jin X; Guo S; Xu F; Su X; Jiang X; Wang G
    Aging (Albany NY); 2021 Feb; 13(4):5506-5524. PubMed ID: 33536348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Model of Colorectal Cancer Constructed by Eight Immune-Related Genes.
    Wen S; He L; Zhong Z; Mi H; Liu F
    Front Mol Biosci; 2020; 7():604252. PubMed ID: 33330631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the potential mechanisms of Yi-Yi-Fu-Zi-Bai-Jiang-San therapy on the immune-inflamed phenotype of colorectal cancer via combined network pharmacology and bioinformatics analyses.
    Liu Y; Liang Y; Su Y; Hu J; Sun J; Zheng M; Huang Z
    Comput Biol Med; 2023 Nov; 166():107432. PubMed ID: 37729701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
    Yang C; Cao F; Huang S; Zheng Y
    Front Immunol; 2021; 12():717505. PubMed ID: 34335633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Robust Prognostic Signature of Tumor Microenvironment in Colorectal Cancer.
    Liu J; Yu F; Liu Z; Wang X; Li J
    Cancer Biother Radiopharm; 2022 Dec; 37(10):963-975. PubMed ID: 34551265
    [No Abstract]   [Full Text] [Related]  

  • 15. Exploration and validation of a combined immune and metabolism gene signature for prognosis prediction of colorectal cancer.
    Xiao Y; Zhang G; Wang L; Liang M
    Front Endocrinol (Lausanne); 2022; 13():1069528. PubMed ID: 36518242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors.
    Wu P; Sun W; Zhang H
    Cancer Immunol Immunother; 2022 Mar; 71(3):747-759. PubMed ID: 34398303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
    Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
    Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
    Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
    Front Immunol; 2022; 13():994874. PubMed ID: 36330513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
    Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
    Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a prognostic gene signature based on an immunogenomic landscape analysis of bladder cancer.
    Luo Y; Chen L; Zhou Q; Xiong Y; Wang G; Liu X; Xiao Y; Ju L; Wang X
    J Cell Mol Med; 2020 Nov; 24(22):13370-13382. PubMed ID: 33048468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.